Genomics to select treatment for patients with metastatic breast cancer

Autor:	Fabrice Andre, Thomas Filleron, Maud Kamal, Fernanda Mosele, Monica Arnedos, Florence Dalenc, Marie-Paule Sablin, Mario Campone, Hervé Bonnefoi, Claudia Lefeuvre-Plesse, William Jacot, Florence Coussy, Jean-Marc Ferrero, George Emile, Marie-Ange Mouret-Reynier, Jean-Christophe Thery, Nicolas Isambert, Alice Mege, Philippe Barthelemy, Benoit You, Nawale Hajjaji, Ludovic Lacroix, Etienne Rouleau, Alicia Tran-Dien, Sandrine Boyault, Valery Attignon, Pierre Gestraud, Nicolas Servant, Christophe Le Tourneau, Linda Larbi Cherif, Isabelle Soubeyran, Filippo Montemurro, Alain Morel, Amelie Lusque, Marta Jimenez, Alexandra Jacquet, Anthony Gonçalves, Thomas Bachelot, Ivan Bieche
Přispěvatelé:	Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA)
Rok vydání:	2022
Předmět:	Multidisciplinary Genome Human [SDV]Life Sciences [q-bio] Clinical Decision-Making DNA Mutational Analysis Genes BRCA2 Genes BRCA1 Breast Neoplasms Genomics Piperazines Disease Progression Humans Phthalazines Female Neoplasm Metastasis
Zdroj:	Nature Nature, 2022, 610 (7931), pp.343-348. ⟨10.1038/s41586-022-05068-3⟩
ISSN:	1476-4687 0028-0836
Popis:	Cancer progression is driven in part by genomic alterations
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e11b6e4a3a2c6123cb66ae86667e677e https://doi.org/10.1038/s41586-022-05068-3 Zobrazit plný text záznamu Full text from SpringerLink